Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory T cells in lung disease and transplantation. | Biosci Rep | 2023 | 37795866 | PubTator, text mining | PubMed |
| Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists. | Front Immunol | 2023 | 37795079 | PubTator, text mining | PubMed |
Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3+ dendritic cells with CD4+ regulatory T cells and CD8+ exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications. | Cancer Commun (Lond) | 2023 | 37794698 | PubTator, text mining | PubMed |
| Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma. | Front Immunol | 2023 | 37790933 | PubTator, text mining | PubMed |
| RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma. | Int J Gen Med | 2023 | 37789880 | PubTator, text mining | PubMed |
| USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis. | J Clin Invest | 2023 | 37788092 | PubTator, text mining | PubMed |
| Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37781718 | PubTator, text mining | PubMed |
| Identification of novel lactate metabolism-related lncRNAs with prognostic value for bladder cancer. | Front Pharmacol | 2023 | 37781694 | PubTator, text mining | PubMed |
| Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics. | Int J Biol Sci | 2023 | 37781030 | PubTator, text mining | PubMed |
| Endogenous retrovirus group FRD member 1 is a potential biomarker for prognosis and immunotherapy for kidney renal clear cell carcinoma. | Front Cell Infect Microbiol | 2023 | 37780849 | PubTator, text mining | PubMed |
| Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer. | Front Med (Lausanne) | 2023 | 37780567 | PubTator, text mining | PubMed |
| Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies. | Transl Oncol | 2023 | 37776617 | PubTator, text mining | PubMed |
| A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs. | Sci Rep | 2023 | 37770477 | PubTator, text mining | PubMed |
| Applications of Curcumin and Its Nanoforms in the Treatment of Cancer. | Pharmaceutics | 2023 | 37765192 | PubTator, text mining | PubMed |
| Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis? | Pathogens | 2023 | 37764924 | PubTator, text mining | PubMed |
| Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible? | Life (Basel) | 2023 | 37763334 | PubTator, text mining | PubMed |
| High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer. | Int J Mol Sci | 2023 | 37761986 | PubTator, text mining | PubMed |
| A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments. | Biomedicines | 2023 | 37760930 | PubTator, text mining | PubMed |
| Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. | Cancers (Basel) | 2023 | 37760450 | PubTator, text mining | PubMed |
| Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review. | Front Immunol | 2023 | 37753092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=18